Medtronic plc Share Price

Equities

MDT

IE00BTN1Y115

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 21:00:02 30/05/2024 BST Pre-market 12:47:15
80.6 USD -1.09% Intraday chart for Medtronic plc 81.48 +1.09%
Sales 2024 32.36B 2,545B Sales 2025 * 33.42B 2,628B Capitalization 106B 8,311B
Net income 2024 3.68B 289B Net income 2025 * 4.99B 393B EV / Sales 2024 4.01 x
Net Debt 2024 23.74B 1,867B Net Debt 2025 * 20.36B 1,601B EV / Sales 2025 * 3.77 x
P/E ratio 2024
28.9 x
P/E ratio 2025 *
22.2 x
Employees 95,000
Yield 2024
3.51%
Yield 2025 *
3.4%
Free-Float 99.78%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.09%
1 week-0.96%
Current month+0.45%
1 month+0.45%
3 months-3.59%
6 months+1.68%
Current year-2.16%
More quotes
1 week
80.46
Extreme 80.46
82.74
1 month
80.13
Extreme 80.13
86.17
Current year
78.43
Extreme 78.43
89.18
1 year
68.84
Extreme 68.84
91.00
3 years
68.84
Extreme 68.84
135.89
5 years
68.84
Extreme 68.84
135.89
10 years
55.54
Extreme 55.54
135.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 25/01/15
Director of Finance/CFO 58 31/05/16
Chief Operating Officer 63 31/03/21
Members of the board TitleAgeSince
Director/Board Member 62 31/12/12
Director/Board Member 70 31/12/06
Director/Board Member 68 31/12/14
More insiders
Date Price Change Volume
30/05/24 80.6 -1.09% 8,871,618
29/05/24 81.49 -0.62% 7,910,489
28/05/24 82 -0.35% 7,478,985
24/05/24 82.29 +1.12% 8,732,273
23/05/24 81.38 -5.11% 10,712,261

Delayed Quote Nyse, May 30, 2024 at 09:00 pm

More quotes
Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.6 USD
Average target price
94.07 USD
Spread / Average Target
+16.71%
Consensus